

CLASSIFICATION:
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: 1 PEN x 1 MG - 4 DOSES)
ACTIVE HALF-LIFE: N/A
DOSAGE: MEN N/A
ACNE: N/A
WATER RETENTION: N/A
HBR: N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: NOVO NORDISK
Please log in to write OZEMPIC 1 MG review.
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HIGH BLOOD PRESSURE (HBP)): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HIGH BLOOD PRESSURE (HBP)): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS